Medicine & Health

The latest National Institutes of Health (NIH) grant for Abhinav Jha at the McKelvey School of Engineering is another step toward early prediction of therapy response in patients with lung cancer.

Washington University School of Medicine in St. Louis has joined the NIH’s SenNet, a national research network focused on understanding senescent cells, an elusive but important cell type that plays key roles in the diseases of aging.

Researchers at Washington University School of Medicine have surveyed cancer doctors to identify differences in physician attitudes and beliefs that may contribute to a gap in referrals to genetic counseling and testing between Black women and white women with breast cancer.

A new study from Washington University School of Medicine estimates that 78% to 92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patient’s tumor.

Kelly L. Bolton, MD, PhD, assistant professor of medicine at the School of Medicine, is one of six early-career physician-scientists to receive the 2021 Damon Runyon Clinical Investigator award from the Damon Runyon Cancer Research Foundation.

Carmen R. Bergom, MD, PhD, associate professor of radiation oncology at Washington University School of Medicine, has been elected to a three-year term as a councilor-at-large for the Radiation Research Society.

Jeff M. Michalski, MD, the Carlos A. Perez Distinguished Professor and vice chair and director of clinical programs in the Department of Radiation Oncology at the School of Medicine, has been elected president-elect of the American Society for Radiation Oncology board of directors.

The School of Medicine is accepting applications for the American Cancer Society Institutional Research Grant to support junior faculty conducting cancer research pilot projects.

Two studies led by Washington University School of Medicine describe the potential of liquid biopsies to identify and track tumor growth in bladder cancer and peripheral nerve tumors. The studies demonstrate the possible benefits of this relatively new tool in the fight against cancer.

Applications are being accepted for the Specialized Programs of Research Excellence (SPORE) in Leukemia Career Enhancement Program. Interested junior researchers should apply by Sept. 15.